GAM
TCRT icon

Gotham Asset Management’s Alaunos Therapeutics TCRT Stock Holding History

Gotham Asset Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-106
Closed -$68K – 1210
2019
Q3 		$68K Buy
106
+13
+14% +$10.3K ﹤0.01% 1059
2019
Q2 		$81K Buy
+93
New +$64K ﹤0.01% 1103
2016
Q3 		– Sell
-285
Closed -$235K – 1041
2016
Q2 		$235K Sell
285
-358
-56% -$390K ﹤0.01% 858
2016
Q1 		$715K Sell
643
-91
-12% -$93.1K 0.01% 702
2015
Q4 		$915K Buy
+734
New +$1.21M 0.01% 615
2015
Q2 		– Sell
-727
Closed -$1.18M – 1040
2015
Q1 		$1.18M Buy
+727
New +$1.08M 0.01% 575

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gotham Asset Management's TCRT Position: Q4 2019 in Review

Gotham Asset Management sold out of Alaunos Therapeutics (TCRT) in Q4 2019, closing a stake of 106 shares — an estimated $68K sold.

Gotham Asset Management first reported a position in TCRT in Q1 2015 and held it in 6 quarters. The position peaked at $1.18M in Q1 2015. 148 funds tracked by Wall St. Rank hold TCRT as of Q4 2019.

  • Gotham Asset Management reported no remaining Alaunos Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Gotham Asset Management sold 106 Alaunos Therapeutics shares in Q4 2019, an estimated $68K.
  • Gotham Asset Management first reported a position in Alaunos Therapeutics in Q1 2015 and held it in 6 quarters.
  • Gotham Asset Management's Alaunos Therapeutics position peaked at $1.18M in Q1 2015.
  • 148 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2019.

Based on Gotham Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.